Transcranial Photobiomodulation Therapy for Sexual Dysfunction Associated with Depression or Induced by Antidepressant Medications (2022)

by 

Farzad Salehpour

 ^1,2,

Mahsa Khademi

 ³,

Farzan Vahedifard

 ⁴ and

Paolo Cassano

 ^5,6,7,8,*

¹

College for Light Medicine and Photobiomodulation, D-82319 Starnberg, Germany

²

ProNeuroLIGHT LLC, Phoenix, AZ 85083, USA

³

Neurosciences Research Center (NSRC), Tabriz University of Medical Sciences, Tabriz 51666, Iran

⁴

Division of Neuroradiology, Rush University, Chicago, IL 60612, USA

⁵

Department of Psychiatry, Harvard Medical School, Boston, MA 02110, USA

⁶

Department of Psychiatry, Division of Neuropsychiatry, Massachusetts General Hospital, Boston, MA 02110, USA

⁷

Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02110, USA

⁸

Center for Anxiety and Traumatic Stress Disorders, Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02110, USA

^*

Author to whom correspondence should be addressed.

Photonics 2022, 9(5), 330; https://doi.org/10.3390/photonics9050330

Received: 31 March 2022 / Revised: 15 April 2022 / Accepted: 15 April 2022 / Published: 11 May 2022

Full text: https://www.mdpi.com/2304-6732/9/5/330

This review reports improvements in symptoms of sexual dysfunction caused by depression or antidepressants, depression and anhedonia through a type of transcranial laser treatment. 

Waldinger's 2014 PSSD case report is mentioned in which a local laser treatment to the genitals had resulted in symptom improvement of genital anaesthesia.

Questa review riporta miglioramenti sui sintomi di disfunzione sessuale causata da depressione o antidepressivi, depressione e anedonia tramite un tipo di trattamento laser transcranico. 

Viene menzionato il case report di PSSD di Waldinger del 2014 in cui un trattamento laser locale ai genitali aveva comportato il miglioramento del sintomo dell'anestesia genitale.